COVID A
UTHORS
Online profiles of coronavirus experts
Return to Top
Zhao Wu
Institution
Peking University First Hospital
Address
Beijing
China
vCard
Download vCard
Publication Timeline
COVID-19 publications
All Publications
These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.
To see the data from both graphs as text,
click here
.
Year
Publications
2005
1
2008
2
2009
1
2011
3
2012
3
2013
8
2014
8
2015
8
2016
7
2017
7
2018
14
2019
4
2020
6
2021
1
These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.
To return to the graphs,
click here
.
Publication Field Summary
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text,
click here
.
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text,
click here
.
Publication List
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Show:
All coronarirus related publications
|
Covid-19 specific publications
|
All publications
Sort By:
Newest
|
Oldest
|
Most Cited
|
Most Discussed
PMC Citations
indicate the number of times the publication was cited by articles in PubMed Central, and the
Altmetric
score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.)
Fields
are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation
tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
Zhao H
,
Zhang C
,
Zhu Q
,
Chen X
,
Chen G
,
Sun W
,
Xiao Z
,
Du W
,
Yao J
,
Li G
,
Ji Y
,
Li N
,
Jiang Y
,
Wang Y
,
Zeng Q
,
Li W
,
Gong B
,
Chang X
,
Zhu F
,
Jiang X
,
Li J
,
Wu Z
,
Liu Y
,
Peng P
,
Wang G
. Favipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: A multicenter, open-label, randomized trial. Int Immunopharmacol. 2021 Aug; 97:107702.
PMID:
33930706
.
Citations:
4
Fields:
All
Allergy and Immunology
Pha
Pharmacology
Translation:
Humans
Cells
Zhang C
,
Mu J
,
Zhang D
,
Li J
,
Wang H
,
Jin Y
,
Han Y
,
Li H
,
Zhang C
,
Yu P
,
Guo R
,
Dou X
,
Chu Y
,
Wu Z
,
Dong X
,
Wang G
,
Zhao H
. Diverse clinical processes of 16 COVID-19 cases who concentrated infection in the same workplace in Beijing, China: An observational study. Medicine (Baltimore). 2020 Dec 24; 99(52):e23800.
PMID:
33350766
.
Citations:
Fields:
Med
Medicine (General)
Translation:
Humans
PH
Public Health
Zhang C
,
Wu Z
,
Li JW
,
Tan K
,
Yang W
,
Zhao H
,
Wang GQ
. Discharge may not be the end of treatment: Pay attention to pulmonary fibrosis caused by severe COVID-19. J Med Virol. 2021 03; 93(3):1378-1386.
PMID:
33107641
.
Citations:
14
Fields:
Vir
Virology
Translation:
Humans
Cells
Zhao H
,
Zhu Q
,
Zhang C
,
Li J
,
Wei M
,
Qin Y
,
Chen G
,
Wang K
,
Yu J
,
Wu Z
,
Chen X
,
Wang G
. Tocilizumab combined with favipiravir in the treatment of COVID-19: A multicenter trial in a small sample size. Biomed Pharmacother. 2021 Jan; 133:110825.
PMID:
33378989
.
Citations:
17
Fields:
Bio
Biology
Dru
Drug Therapy
Med
Medicine (General)
Translation:
Humans
Zhang C
,
Li J
,
Wu Z
,
Wang H
,
Que C
,
Zhao H
,
Wang G
. Efficacy and safety of Anluohuaxian in the treatment of patients with severe Coronavirus disease 2019- a multicenter, open label, randomized controlled study: a structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 08; 21(1):495.
PMID:
32513299
.
Citations:
2
Fields:
Med
Medicine (General)
The
Therapeutics
Translation:
Humans
Cells
PH
Public Health
CT
Clinical Trials
Li J
,
Zhang C
,
Wu Z
,
Wang G
,
Zhao H
. The Mechanism and Clinical Outcome of patients with Corona Virus Disease 2019 Whose Nucleic Acid Test has changed from negative to positive, and the therapeutic efficacy of Favipiravir: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 05; 21(1):488.
PMID:
32503657
.
Citations:
5
Fields:
Med
Medicine (General)
The
Therapeutics
Translation:
Humans
Cells
PH
Public Health
CT
Clinical Trials
Zhang C
,
Wu Z
,
Li JW
,
Zhao H
,
Wang GQ
. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020 May; 55(5):105954.
PMID:
32234467
.
Citations:
647
Fields:
Ant
Anti-Infective Agents
Translation:
Humans
Cells
PH
Public Health
Start with:
newest
oldest
Include:
line numbers
double spacing
all authors
publication IDs